US 11,883,425 B2
Metformin compositions and methods for treatment of diabetes
William H. Cross, III, Waco, GA (US)
Filed by William H. Cross, III, Waco, GA (US)
Filed on Apr. 18, 2022, as Appl. No. 17/659,537.
Application 17/659,537 is a continuation of application No. 16/264,595, filed on Jan. 31, 2019, granted, now 11,304,971.
Claims priority of provisional application 62/624,729, filed on Jan. 31, 2018.
Prior Publication US 2022/0233574 A1, Jul. 28, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/714 (2006.01); A61K 31/185 (2006.01); A61K 31/4045 (2006.01); A61K 31/155 (2006.01); A61P 3/10 (2006.01); A61K 31/198 (2006.01)
CPC A61K 31/714 (2013.01) [A61K 31/155 (2013.01); A61K 31/185 (2013.01); A61K 31/198 (2013.01); A61K 31/4045 (2013.01); A61P 3/10 (2018.01)] 20 Claims
 
1. A composition for treatment of diabetes comprising a pharmaceutically effective amount of metformin and
(a) taurine;
(b) citrulline;
(c) methylcobalamin; and
(d) beta-alanine.